HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drugstore.com S&E

This article was originally published in The Rose Sheet

Executive Summary

September relaunch of beauty.com Web site has increased traffic to the site by 40%, fueling the firm's beauty sales growth by 45% in 2007, firm reports during Feb. 6 analyst meeting. "Additionally, we are seeing positive results from the launch of our personalized skin care diagnostic as skin-care sales were up 65%, and from our hair care consultation tool where hair care was the highest growth category, up 78%," President and CEO Dawn G. Lepore says. Performance of the business also was boosted by the addition of prestige brands Stila and Lancaster, which were among 50 prestige brands added to the Web site in 2007, exec notes. In 2008, drugstore.com believes it can grow the beauty business by more than 50% year-over-year. Drugstore.com's net sales for the full year grew 7.2% to 445.7 mil., though firm experienced a loss during the quarter of $9 mil., an improvement over $13 mil. loss last year...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS015228

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel